GLYCOPYRROLATE and COUGH

Overview

COUGH is the #4 most commonly reported adverse reaction for GLYCOPYRROLATE, manufactured by Merz Pharmaceuticals, LLC. There are 626 FDA adverse event reports linking GLYCOPYRROLATE to COUGH. This represents approximately 3.2% of all 19,591 adverse event reports for this drug.

Patients taking GLYCOPYRROLATE who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH is moderately reported among GLYCOPYRROLATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of GLYCOPYRROLATE

In addition to cough, the following adverse reactions have been reported for GLYCOPYRROLATE:

• DYSPNOEA — 1,000 reports
• ASTHMA — 793 reports
• WHEEZING — 674 reports
• PNEUMONIA — 538 reports
• DRUG INEFFECTIVE — 411 reports
• FATIGUE — 352 reports
• OFF LABEL USE — 351 reports
• MALAISE — 345 reports
• PRODUCTIVE COUGH — 330 reports
• CHEST DISCOMFORT — 327 reports

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

Does GLYCOPYRROLATE cause COUGH?

COUGH has been reported as an adverse event in 626 FDA reports for GLYCOPYRROLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with GLYCOPYRROLATE?

COUGH accounts for approximately 3.2% of all adverse event reports for GLYCOPYRROLATE, making it a notable side effect.

What should I do if I experience COUGH while taking GLYCOPYRROLATE?

If you experience cough while taking GLYCOPYRROLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages